A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination therapy in Subjects with Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Project: Research

Project Details

Effective start/end date28/10/1931/12/24


  • Cystic Fibrosis
  • Clinical trial